Is Aspirin monotherapy effective for stroke prevention in the real world? A UK cohort study evaluating the incidence of stroke in the absence of anticoagulation in atrial fibrillation (AF)

28 August 2016 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster session 3 - Anticoagulation in atrial fibrillation II Atrial fibrillation (AF) ESC Premium Access ESC Congress 2016

About the speaker

Photo

Bristol-Myers Squibb Pharmaceuticals Limited , London (United Kingdom of Great Britain & Northern Ireland)

22 More presentations in this session

Presentation thumbnail
Doctor A. Nissen Bonde (Roskilde, DK)
Presentation thumbnail
Doctor E. Nguyen (Storrs, US)
Presentation thumbnail
Doctor G. Laugaudin (Montpellier, FR)
Presentation thumbnail
Professor J. Piccini (Durham, US)
Presentation thumbnail
Professor G. Lip (Liverpool, GB)

The Event

Event poster

ESC Congress 2016

28 August 2016 14:00 CET

ESC 365 is supported by

ESC 365 is supported by